CNCS Center for Nonlinear and Complex Systems
   Search Help Login pdf version printable version

Publications of Andrew D. Krystal    :chronological  alphabetical  combined  bibtex listing:

Papers Published

  1. McCall, WV; Benca, RM; Rumble, ME; Case, D; Rosenquist, PB; Krystal, AD, Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder., J Psychiatr Res, vol. 116 (September, 2019), pp. 147-150 [doi]  [abs]
  2. Scangos, KW; Weiner, RD; Coffey, EC; Krystal, AD, An Electrophysiological Biomarker That May Predict Treatment Response to ECT., J Ect, vol. 35 no. 2 (June, 2019), pp. 95-102 [doi]  [abs]
  3. Asarnow, LD; Bei, B; Krystal, A; Buysse, DJ; Thase, ME; Edinger, JD; Manber, R, Circadian Preference as a Moderator of Depression Outcome Following Cognitive Behavioral Therapy for Insomnia Plus Antidepressant Medications: A Report From the TRIAD Study., J Clin Sleep Med, vol. 15 no. 4 (April, 2019), pp. 573-580 [doi]  [abs]
  4. Herring, WJ; Roth, T; Krystal, AD; Michelson, D, Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications., J Sleep Res, vol. 28 no. 2 (April, 2019), pp. e12782 [doi]  [abs]
  5. Strollo, PJ; Hedner, J; Collop, N; Lorch, DG; Chen, D; Carter, LP; Lu, Y; Lee, L; Black, J; Pépin, J-L; Redline, S; Tones 4 Study Investigators,, Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study., Chest, vol. 155 no. 2 (February, 2019), pp. 364-374 [doi]  [abs]
  6. Krystal, AD; Prather, AA, Sleep Pharmacogenetics: The Promise of Precision Medicine, Sleep Medicine Clinics (January, 2019) [doi]  [abs]
  7. Ohayon, MM; Black, J; Krystal, AD; Shapiro, CM; Swick, TJ; Bogan, R; Wells, CC, Longitudinal study of narcolepsy symptoms in first, second, and third-degree relatives of simplex and multiplex narcolepsy families., Sleep Med, vol. 53 (January, 2019), pp. 88-93 [doi]  [abs]
  8. La, AL; Walsh, CM; Neylan, TC; Vossel, KA; Yaffe, K; Krystal, AD; Miller, BL; Karageorgiou, E, Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers., J Alzheimers Dis, vol. 67 no. 3 (2019), pp. 911-921 [doi]  [abs]
  9. Krystal, AD; Pizzagalli, DA; Mathew, SJ; Sanacora, G; Keefe, R; Song, A; Calabrese, J; Goddard, A; Goodman, W; Lisanby, SH; Smoski, M; Weiner, R; Iosifescu, D; Nurnberger, J; Szabo, S; Murrough, J; Shekhar, A; Potter, W, The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development., Nat Rev Drug Discov, vol. 18 no. 1 (December, 2018), pp. 82-84 [doi]
  10. Dominguez, JE; Habib, AS; Krystal, AD, A review of the associations between obstructive sleep apnea and hypertensive disorders of pregnancy and possible mechanisms of disease., Sleep Med Rev, vol. 42 (December, 2018), pp. 37-46 [doi]  [abs]
  11. Dominguez, JE; Grotegut, CA; Cooter, M; Krystal, AD; Habib, AS, Screening extremely obese pregnant women for obstructive sleep apnea., American Journal of Obstetrics and Gynecology, vol. 219 no. 6 (December, 2018), pp. 613.e1-613.e10 [doi]  [abs]
  12. Szabo, ST; Kandra, K; Krystal, AD, Effect of γ-hydroxybutyrate (Xyrem) on locus coeruleus activity as measured by pupillometry in a patient with narcolepsy., International Journal of Clinical Pharmacology and Therapeutics, vol. 56 no. 12 (December, 2018), pp. 620-622 [doi]
  13. Dominguez, JE; Krystal, AD; Habib, AS, Obstructive Sleep Apnea in Pregnant Women: A Review of Pregnancy Outcomes and an Approach to Management., Anesth Analg, vol. 127 no. 5 (November, 2018), pp. 1167-1177 [doi]  [abs]
  14. Lundeen, J; McCall, WV; Krystal, A; Looney, S, Validating functional data analysis measures from 24-h actigraphy data, Biological Rhythm Research, vol. 49 no. 5 (September, 2018), pp. 797-810, Informa UK Limited [doi]  [abs]
  15. Beppler, EC; Dieffenderfer, J; Songkakul, T; Krystal, A; Bozkurt, A, An Ultra-miniaturized Near Infrared Spectroscopy System to Assess Sleep Apnea in Children with Down Syndrome., Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference, vol. 2018 (July, 2018), pp. 2877-2880 [doi]  [abs]
  16. Bei, B; Asarnow, LD; Krystal, A; Edinger, JD; Buysse, DJ; Manber, R, Treating insomnia in depression: Insomnia related factors predict long-term depression trajectories., J Consult Clin Psychol, vol. 86 no. 3 (March, 2018), pp. 282-293, American Psychological Association (APA) [doi]  [abs]
  17. Rumble, ME; Dickson, D; McCall, WV; Krystal, AD; Case, D; Rosenquist, PB; Benca, RM, The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review., J Affect Disord, vol. 227 (February, 2018), pp. 721-730 [doi]  [abs]
  18. Valero-Sarmiento, JM; Reynolds, J; Krystal, A; Bozkurt, A, In vitro evaluation of an injectable EEG/ECG sensor for wireless monitoring of hibernation in endangered animal species, Ieee Sensors Journal, vol. 18 no. 2 (January, 2018), pp. 798-808, Institute of Electrical and Electronics Engineers (IEEE) [doi]  [abs]
  19. Loo, CK; Husain, MM; McDonald, WM; Aaronson, S; O'Reardon, JP; Alonzo, A; Weickert, CS; Martin, DM; McClintock, SM; Mohan, A; Lisanby, SH; International Consortium of Research in tDCS (ICRT),, International randomized-controlled trial of transcranial Direct Current Stimulation in depression., Brain Stimul, vol. 11 no. 1 (January, 2018), pp. 125-133 [doi]  [abs]
  20. McClintock, SM; Reti, IM; Carpenter, LL; McDonald, WM; Dubin, M; Taylor, SF; Cook, IA; O'Reardon, J; Husain, MM; Wall, C; Krystal, A; Sampson, S; Morales, O; Nelson, BG; George, MS; Lisanby, SH, Dr McClintock and Colleagues Reply., The Journal of Clinical Psychiatry, vol. 79 no. 1 (January, 2018) [doi]
  21. McClintock, SM; Reti, IM; Carpenter, LL; McDonald, WM; Dubin, M; Taylor, SF; Cook, IA; O'Reardon, J; Husain, MM; Wall, C; Krystal, AD; Sampson, SM; Morales, O; Nelson, BG; Latoussakis, V; George, MS; Lisanby, SH; National Network of Depression Centers rTMS Task Group, ; American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments,, Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression., The Journal of Clinical Psychiatry, vol. 79 no. 1 (January, 2018) [doi]  [abs]
  22. Goucher Miranda, H; Krystal, AD; Fierro, MA, Nocturnal Dexmedetomidine in Nonintubated, Critically Ill Patients: Sleep or Sedation?, Anesthesiology, vol. 127 no. 2 (August, 2017), pp. 397-398 [doi]
  23. Connor, KM; Ceesay, P; Hutzelmann, J; Snavely, D; Krystal, AD; Trivedi, MH; Thase, M; Lines, C; Herring, WJ; Michelson, D, Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder., The International Journal of Neuropsychopharmacology, vol. 20 no. 8 (August, 2017), pp. 613-618 [doi]  [abs]
  24. Evans, JL; Nadler, JW; Preud'homme, XA; Fang, E; Daughtry, RL; Chapman, JB; Attarian, D; Wellman, S; Krystal, AD, Pilot prospective study of post-surgery sleep and EEG predictors of post-operative delirium., Clin Neurophysiol, vol. 128 no. 8 (August, 2017), pp. 1421-1425 [doi]  [abs]
  25. Samson, DR; Manus, MB; Krystal, AD; Fakir, E; Yu, JJ; Nunn, CL, Segmented sleep in a nonelectric, small-scale agricultural society in Madagascar., Am J Hum Biol, vol. 29 no. 4 (July, 2017) [doi]  [abs]
  26. Herring, WJ; Connor, KM; Snyder, E; Snavely, DB; Zhang, Y; Hutzelmann, J; Matzura-Wolfe, D; Benca, RM; Krystal, AD; Walsh, JK; Lines, C; Roth, T; Michelson, D, Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials., Am J Geriatr Psychiatry, vol. 25 no. 7 (July, 2017), pp. 791-802 [doi]  [abs]
  27. Sateia, MJ; Buysse, DJ; Krystal, AD; Neubauer, DN, Adverse Effects of Hypnotic Medications., J Clin Sleep Med, vol. 13 no. 6 (June, 2017), pp. 839 [doi]
  28. Herring, WJ; Connor, KM; Snyder, E; Snavely, DB; Zhang, Y; Hutzelmann, J; Matzura-Wolfe, D; Benca, RM; Krystal, AD; Walsh, JK; Lines, C; Roth, T; Michelson, D, Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data., Psychopharmacology (Berl), vol. 234 no. 11 (June, 2017), pp. 1703-1711 [doi]  [abs]
  29. Nadler, JW; Evans, JL; Fang, E; Preud'Homme, XA; Daughtry, RL; Chapman, JB; Bolognesi, MP; Attarian, DE; Wellman, SS; Krystal, AD, A randomised trial of peri-operative positive airway pressure for postoperative delirium in patients at risk for obstructive sleep apnoea after regional anaesthesia with sedation or general anaesthesia for joint arthroplasty., Anaesthesia, vol. 72 no. 6 (June, 2017), pp. 729-736 [doi]  [abs]
  30. Carney, CE; Edinger, JD; Kuchibhatla, M; Lachowski, AM; Bogouslavsky, O; Krystal, AD; Shapiro, CM, Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial., Sleep, vol. 40 no. 4 (April, 2017) [doi]  [abs]
  31. Edinger, JD; Manber, R; Buysse, DJ; Krystal, AD; Thase, ME; Gehrman, P; Fairholme, CP; Luther, J; Wisniewski, S, Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study., J Clin Sleep Med, vol. 13 no. 2 (February, 2017), pp. 205-213 [doi]  [abs]
  32. Sateia, MJ; Buysse, DJ; Krystal, AD; Neubauer, DN; Heald, JL, Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline., J Clin Sleep Med, vol. 13 no. 2 (February, 2017), pp. 307-349 [doi]  [abs]
  33. Ohayon, M; Wickwire, EM; Hirshkowitz, M; Albert, SM; Avidan, A; Daly, FJ; Dauvilliers, Y; Ferri, R; Fung, C; Gozal, D; Hazen, N; Krystal, A; Lichstein, K; Mallampalli, M; Plazzi, G; Rawding, R; Scheer, FA; Somers, V; Vitiello, MV, National Sleep Foundation's sleep quality recommendations: first report., Sleep Health, vol. 3 no. 1 (February, 2017), pp. 6-19 [doi]  [abs]
  34. Krystal, AD; Prather, AA, Should Internet Cognitive Behavioral Therapy for Insomnia Be the Primary Treatment Option for Insomnia?: Toward Getting More SHUTi., Jama Psychiatry, vol. 74 no. 1 (January, 2017), pp. 15-16 [doi]
  35. McCall, WV; Benca, RM; Rosenquist, PB; Riley, MA; McCloud, L; Newman, JC; Case, D; Rumble, M; Krystal, AD, Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA., American Journal of Psychiatry, vol. 174 no. 1 (January, 2017), pp. 18-25 [doi]  [abs]
  36. Bathgate, CJ; Edinger, JD; Krystal, AD, Insomnia Patients With Objective Short Sleep Duration Have a Blunted Response to Cognitive Behavioral Therapy for Insomnia., Sleep, vol. 40 no. 1 (January, 2017) [doi]  [abs]
  37. Krystal, AD; Preud'homme, XA, Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia., Sleep, vol. 40 no. 1 (January, 2017) [doi]  [abs]
  38. Lunsford-Avery, JR; Krystal, AD; Kollins, SH, Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research., Clin Psychol Rev, vol. 50 (December, 2016), pp. 159-174 [doi]  [abs]
  39. Ptáǒek, LJ; Fu, Y-H; Krystal, AD, Sleep and Mood: Chicken or Egg?, Biol Psychiatry, vol. 80 no. 11 (December, 2016), pp. 810-811 [doi]
  40. Jacobsen, JPR; Krystal, AD; Krishnan, KRR; Caron, MG, Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale., Trends Pharmacol Sci, vol. 37 no. 11 (November, 2016), pp. 933-944 [doi]  [abs]
  41. Carlezon, WA; Krystal, AD, Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials., Depress Anxiety, vol. 33 no. 10 (October, 2016), pp. 895-906 [doi]  [abs]
  42. Herring, WJ; Connor, KM; Snyder, E; Snavely, DB; Zhang, Y; Hutzelmann, J; Matzura-Wolfe, D; Benca, RM; Krystal, AD; Walsh, JK; Lines, C; Roth, T; Michelson, D, Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials., J Clin Sleep Med, vol. 12 no. 9 (September, 2016), pp. 1215-1225 [doi]  [abs]
  43. Bathgate, CJ; Edinger, JD; Krystal, AD, Insomnia Patients with Objective Short Sleep Duration have a Blunted Response to Cognitive Behavioral Therapy for Insomnia., Sleep (September, 2016)  [abs]
  44. Krystal, AD; Preud'homme, XA, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER, STUDY OF ARMODAFINIL TREATMENT OF DAYTIME SLEEPINESS ASSOCIATED WITH TREATED NOCTURIA., Sleep (September, 2016)  [abs]
  45. Krystal, AD; Mittoux, A; Meisels, P; Baker, RA, Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study., Prim Care Companion Cns Disord, vol. 18 no. 5 (September, 2016) [doi]  [abs]
  46. Blanco, MB; Dausmann, KH; Faherty, SL; Klopfer, P; Krystal, AD; Schopler, R; Yoder, AD, Hibernation in a primate: does sleep occur?, Royal Society Open Science, vol. 3 no. 8 (August, 2016), pp. 160282 [doi]  [abs]
  47. Krystal, JH; Abi-Dargham, A; Akbarian, S; Arnsten, AFT; Barch, DM; Bearden, CE; Braff, DL; Brown, ES; Bullmore, ET; Carlezon, WA; Carter, CS; Cook, EH; Daskalakis, ZJ; DiLeone, RJ; Duman, RS; Grace, AA; Hariri, AR; Harrison, PJ; Hiroi, N; Kenny, PJ; Kleinman, JE; Krystal, AD; Lewis, DA; Lipska, BK; Marder, SR; Mason, GF; Mathalon, DH; McClung, CA; McDougle, CJ; McIntosh, AM; McMahon, FJ; Mirnics, K; Monteggia, LM; Narendran, R; Nestler, EJ; Neumeister, A; O'Donovan, MC; Öngür, D; Pariante, CM; Paulus, MP; Pearlson, G; Phillips, ML; Pine, DS; Pizzagalli, DA; Pletnikov, MV; Ragland, JD; Rapoport, JL; Ressler, KJ; Russo, SJ; Sanacora, G; Sawa, A; Schatzberg, AF; Shaham, Y; Shamay-Tsoory, SG; Sklar, P; State, MW; Stein, MB; Strakowski, SM; Taylor, SF; Turecki, G; Turetsky, BI; Weissman, MM; Zachariou, V; Zarate, CA; Zubieta, J-K, Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research., Biol Psychiatry, vol. 80 no. 2 (July, 2016), pp. 84-86 [doi]
  48. Bathgate, CJ; Edinger, JD; Wyatt, JK; Krystal, AD, Objective but Not Subjective Short Sleep Duration Associated with Increased Risk for Hypertension in Individuals with Insomnia., Sleep, vol. 39 no. 5 (May, 2016), pp. 1037-1045 [doi]  [abs]
  49. Krystal, AD; Zammit, G, The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia., Hum Psychopharmacol, vol. 31 no. 3 (May, 2016), pp. 206-216 [doi]  [abs]
  50. Krystal, JH; Pietrzak, RH; Rosenheck, RA; Cramer, JA; Vessicchio, J; Jones, KM; Huang, GD; Vertrees, JE; Collins, J; Krystal, AD; Veterans Affairs Cooperative Study #504 Group,, Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504., The Journal of Clinical Psychiatry, vol. 77 no. 4 (April, 2016), pp. 483-491, ISSN 0160-6689 [doi]  [abs]
  51. Krystal, AD; Sorscher, AJ, Recognizing and managing insomnia in primary care and specialty settings., The Journal of Clinical Psychiatry, vol. 77 no. 4 (April, 2016), pp. e471 [doi]  [abs]
  52. Morin, CM; Edinger, JD; Krystal, AD; Buysse, DJ; Beaulieu-Bonneau, S; Ivers, H, Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial., Trials, vol. 17 no. 1 (March, 2016), pp. 118 [doi]  [abs]
  53. Herring, WJ; Connor, KM; Ivgy-May, N; Snyder, E; Liu, K; Snavely, DB; Krystal, AD; Walsh, JK; Benca, RM; Rosenberg, R; Sangal, RB; Budd, K; Hutzelmann, J; Leibensperger, H; Froman, S; Lines, C; Roth, T; Michelson, D, Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials., Biol Psychiatry, vol. 79 no. 2 (January, 2016), pp. 136-148, ISSN 0006-3223 [doi]  [abs]
  54. Nunn, CL; Samson, DR; Krystal, AD, Shining evolutionary light on human sleep and sleep disorders., Evolution, Medicine, and Public Health, vol. 2016 no. 1 (2016), pp. 227-243 [doi]  [abs]
  55. Krystal, AD, New Developments in Insomnia Medications of Relevance to Mental Health Disorders., Psychiatr Clin North Am, vol. 38 no. 4 (December, 2015), pp. 843-860, ISSN 0193-953X [doi]  [abs]
  56. Morin, CM; Drake, CL; Harvey, AG; Krystal, AD; Manber, R; Riemann, D; Spiegelhalder, K, Insomnia disorder., Nature Reviews. Disease Primers, vol. 1 (September, 2015), pp. 15026 [doi]  [abs]
  57. Peterchev, AV; Krystal, AD; Rosa, MA; Lisanby, SH, Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy., Neuropsychopharmacology, vol. 40 no. 9 (August, 2015), pp. 2076-2084, ISSN 0893-133X [doi]  [abs]
  58. Krystal, AD, Current, emerging, and newly available insomnia medications., The Journal of Clinical Psychiatry, vol. 76 no. 8 (August, 2015), pp. e1045, ISSN 0160-6689 [doi]  [abs]
  59. Ivgy-May, N; Ruwe, F; Krystal, A; Roth, T, Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial., Sleep Med, vol. 16 no. 7 (July, 2015), pp. 838-844, ISSN 1389-9457 [doi]  [abs]
  60. Leuchter, AF; Cook, IA; Feifel, D; Goethe, JW; Husain, M; Carpenter, LL; Thase, ME; Krystal, AD; Philip, NS; Bhati, MT; Burke, WJ; Howland, RH; Sheline, YI; Aaronson, ST; Iosifescu, DV; O'Reardon, JP; Gilmer, WS; Jain, R; Burgoyne, KS; Phillips, B; Manberg, PJ; Massaro, J; Hunter, AM; Lisanby, SH; George, MS, Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression., Brain Stimul, vol. 8 no. 4 (July, 2015), pp. 787-794, ISSN 1935-861X [doi]  [abs]
  61. Krystal, JH; Stossel, S; Krystal, AD, Restricting Benzodiazepines to Short-Term Prescription., Jama Psychiatry, vol. 72 no. 7 (July, 2015), pp. 734-735, ISSN 2168-622X [doi]
  62. McCall, WV; Benca, RM; Rosenquist, PB; Riley, MA; Hodges, C; Gubosh, B; McCloud, L; Newman, JC; Case, D; Rumble, M; Mayo, M; White, KH; Phillips, M; Krystal, AD, A multi-site randomized clinical trial to reduce suicidal ideation in suicidal adult outpatients with Major Depressive Disorder: Development of a methodology to enhance safety., Clin Trials, vol. 12 no. 3 (June, 2015), pp. 189-198, ISSN 1740-7745 [doi]  [abs]
  63. Rapp, PE; Keyser, DO; Albano, A; Hernandez, R; Gibson, DB; Zambon, RA; David Hairston, W; Hughes, JD; Krystal, A; Nichols, AS, Traumatic brain injury detection using electrophysiological methods, Frontiers in Human Neuroscience, vol. 9 no. FEB (February, 2015), FRONTIERS MEDIA SA [doi]  [abs]
  64. Szabo, ST; Kinon, BJ; Brannan, SK; Krystal, AK; van Gerven, JMA; Mahableshwarkar, A; Sachs, GS, Lessons learned and potentials for improvement in cns drug development: Isctm section on designing the right series of experiments, Innovations in Clinical Neuroscience, vol. 12 no. 3-4 (January, 2015), pp. 11S-25S  [abs]
  65. Tek, C; Palmese, LB; Krystal, AD; Srihari, VH; DeGeorge, PC; Reutenauer, EL; Guloksuz, S, The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial., Schizophrenia Research, vol. 160 no. 1-3 (December, 2014), pp. 180-185, ISSN 0920-9964 [doi]  [abs]
  66. Calabrese, JR; Fava, M; Garibaldi, G; Grunze, H; Krystal, AD; Laughren, T; Macfadden, W; Marin, R; Nierenberg, AA; Tohen, M, Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders., J Affect Disord, vol. 168 (October, 2014), pp. 439-451, ISSN 0165-0327 [doi]  [abs]
  67. Goforth, HW; Preud'homme, XA; Krystal, AD, A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain., Sleep, vol. 37 no. 6 (June, 2014), pp. 1053-1060, ISSN 0161-8105 [doi]  [abs]
  68. McClintock, SM; Choi, J; Deng, Z-D; Appelbaum, LG; Krystal, AD; Lisanby, SH, Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy., J Ect, vol. 30 no. 2 (June, 2014), pp. 165-176, ISSN 1095-0680 [repository], [doi]  [abs]
  69. Michelson, D; Snyder, E; Paradis, E; Chengan-Liu, M; Snavely, DB; Hutzelmann, J; Walsh, JK; Krystal, AD; Benca, RM; Cohn, M; Lines, C; Roth, T; Herring, WJ, Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial., Lancet Neurol, vol. 13 no. 5 (May, 2014), pp. 461-471, ISSN 1474-4422 [doi]  [abs]
  70. Krystal, AD; Zhang, W; Davidson, JRT; Connor, KM, The sleep effects of tiagabine on the first night of treatment predict post-traumatic stress disorder response at three weeks., J Psychopharmacol, vol. 28 no. 5 (May, 2014), pp. 457-465 [24288237], [doi]  [abs]
  71. Mirrakhimov, AE; Brewbaker, CL; Krystal, AD; Kwatra, MM, Obstructive sleep apnea and delirium: exploring possible mechanisms., Sleep Breath, vol. 18 no. 1 (March, 2014), pp. 19-29 [23584846], [doi]  [abs]
  72. Greve, DN; Duntley, SP; Larson-Prior, L; Krystal, AD; Diaz, MT; Drummond, SPA; Thein, SG; Kushida, CA; Yang, R; Thomas, RJ, Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study., J Clin Sleep Med, vol. 10 no. 2 (February, 2014), pp. 143-153, ISSN 1550-9389 [doi]  [abs]
  73. Wang, X; Bey, AL; Chung, L; Krystal, AD; Jiang, Y-H, Therapeutic approaches for shankopathies., Dev Neurobiol, vol. 74 no. 2 (February, 2014), pp. 123-135 [23536326], [doi]  [abs]
  74. Low, Y; Goforth, H; Preud'homme, X; Edinger, J; Krystal, A, Insomnia in HIV-infected patients: pathophysiologic implications., Aids Rev, vol. 16 no. 1 (January, 2014), pp. 3-13, ISSN 1139-6121  [abs]
  75. Minkel, J; Krystal, AD, Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons., Sleep Med Clin, vol. 8 no. 3 (September, 2013), pp. 333-350, ISSN 1556-407X [doi]  [abs]
  76. Edinger, JD; Means, MK; Krystal, AD, Does physiological hyperarousal enhance error rates among insomnia sufferers?, Sleep, vol. 36 no. 8 (August, 2013), pp. 1179-1186 [23904678], [doi]  [abs]
  77. Krystal, AD; Richelson, E; Roth, T, Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications., Sleep Med Rev, vol. 17 no. 4 (August, 2013), pp. 263-272 [23357028], [doi]  [abs]
  78. Preud'homme, XA; Amundsen, CL; Webster, GD; Krystal, AD, Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls., Int Urogynecol J, vol. 24 no. 3 (March, 2013), pp. 501-508 [22855113], [doi]  [abs]
  79. Roth, T; Krystal, A; Steinberg, FJ; Singh, NN; Moline, M, Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study., Sleep, vol. 36 no. 2 (February, 2013), pp. 189-196, ISSN 0161-8105 [doi]  [abs]
  80. Rosenquist, PB; Krystal, A; Heart, KL; Demitrack, MA; McCall, WV, Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder., Psychiatry Research, vol. 205 no. 1-2 (January, 2013), pp. 67-73, ISSN 0165-1781 [doi]  [abs]
  81. Krystal, AD; Benca, RM; Kilduff, TS, Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system., The Journal of Clinical Psychiatry, vol. 74 Suppl 1 (2013), pp. 3-20 [24107804], [doi]
  82. Krystal, AD; Schopler, B; Kobbe, S; Williams, C; Rakatondrainibe, H; Yoder, AD; Klopfer, P, The relationship of sleep with temperature and metabolic rate in a hibernating primate., Plos One, vol. 8 no. 9 (2013), pp. e69914 [24023713], [doi]  [abs]
  83. Krystal, AD, Sleep in Mood Disorders (December, 2012), pp. 675-681, Elsevier [doi]
  84. Low, Y; Goforth, HW; Omonuwa, T; Preud'homme, X; Edinger, J; Krystal, A, Comparison of polysomnographic data in age-, sex- and Axis I psychiatric diagnosis matched HIV-seropositive and HIV-seronegative insomnia patients., Clin Neurophysiol, vol. 123 no. 12 (December, 2012), pp. 2402-2405, ISSN 1388-2457 [doi]  [abs]
  85. Krystal, AD, Psychiatric disorders and sleep., Neurol Clin, vol. 30 no. 4 (November, 2012), pp. 1389-1413 [23099143], [doi]  [abs]
  86. Krystal, AD; Roth, T; Simon, RD, Shift work disorder case studies: applying management principles in clinical practice., The Journal of Clinical Psychiatry, vol. 73 no. 8 (August, 2012), pp. e25 [22967784], [doi]  [abs]
  87. Krystal, AD; Huang, H; Zummo, J; Grinnell, T; Marshall, RD, A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg., Sleep Med, vol. 13 no. 6 (June, 2012), pp. 691-696 [22465450], [doi]  [abs]
  88. Ohayon, MM; Mahowald, MW; Dauvilliers, Y; Krystal, AD; Léger, D, Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population., Neurology, vol. 78 no. 20 (May, 2012), pp. 1583-1589 [22585435], [doi]  [abs]
  89. Flink, BJ; Rivelli, SK; Cox, EA; White, WD; Falcone, G; Vail, TP; Young, CC; Bolognesi, MP; Krystal, AD; Trzepacz, PT; Moon, RE; Kwatra, MM, Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly., Anesthesiology, vol. 116 no. 4 (April, 2012), pp. 788-796 [22337162], [doi]  [abs]
  90. Carney, CE; Buysse, DJ; Ancoli-Israel, S; Edinger, JD; Krystal, AD; Lichstein, KL; Morin, CM, The consensus sleep diary: standardizing prospective sleep self-monitoring., Sleep, vol. 35 no. 2 (February, 2012), pp. 287-302 [22294820], [doi]  [abs]
  91. Krystal, AD, How the circadian rhythm affects sleep, wakefulness, and overall health: background for understanding shift work disorder., The Journal of Clinical Psychiatry, vol. 73 no. 2 (February, 2012), pp. e05 [22401482], [doi]  [abs]
  92. Ulmer, CS; Sutherland, M; Edinger, JD; Davidson, J; Connor, KM; Zhang, W; Krystal, A, REM sleep bout duration and frequency in PTSD, Journal of Aggression, Maltreatment & Trauma, vol. 21 no. 1 (January, 2012), pp. 67-76, Informa UK Limited, ISSN 1092-6771 [doi]  [abs]
  93. Krystal, AD; McCall, WV; Fava, M; Joffe, H; Soares, CN; Huang, H; Grinell, T; Zummo, J; Spalding, W; Marshall, R, Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity., The Primary Care Companion for Cns Disorders, vol. 14 no. 4 (2012), ISSN 2155-7772 [23251857], [doi]  [abs]
  94. Krystal, AD; Sutherland, J; Hochman, DW, Loop diuretics have anxiolytic effects in rat models of conditioned anxiety., Plos One, vol. 7 no. 4 (2012), pp. e35417 [22514741], [doi]  [abs]
  95. Low, Y; Preud'homme, X; Goforth, HW; Omonuwa, T; Krystal, AD, The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study., Sleep, vol. 34 no. 12 (December, 2011), pp. 1723-1726 [22131611], [doi]  [abs]
  96. Palmese, LB; DeGeorge, PC; Ratliff, JC; Srihari, VH; Wexler, BE; Krystal, AD; Tek, C, Insomnia is frequent in schizophrenia and associated with night eating and obesity., Schizophrenia Research, vol. 133 no. 1-3 (December, 2011), pp. 238-243 [21856129], [doi]  [abs]
  97. Rose, JE; McClernon, FJ; Froeliger, B; Behm, FM; Preud'homme, X; Krystal, AD, Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes., Biol Psychiatry, vol. 70 no. 8 (October, 2011), pp. 794-799 [21762878], [doi]  [abs]
  98. Krystal, AD; Lankford, A; Durrence, HH; Ludington, E; Jochelson, P; Rogowski, R; Roth, T, Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia., Sleep, vol. 34 no. 10 (October, 2011), pp. 1433-1442 [21966075], [doi]  [abs]
  99. Edinger, JD; Wyatt, JK; Stepanski, EJ; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Crisostomo, MI; Lineberger, MD; Means, MK; Radtke, RA; Wohlgemuth, WK; Krystal, AD, Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis., Arch Gen Psychiatry, vol. 68 no. 10 (October, 2011), pp. 992-1002 [21646568], [doi]  [abs]
  100. Carney, CE; Moss, TG; Harris, AL; Edinger, JD; Krystal, AD, Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients?, J Psychiatr Res, vol. 45 no. 9 (September, 2011), pp. 1243-1249 [21482427], [doi]  [abs]
  101. Krystal, AD, A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression (Journal of Clinical Psychiatry (2010) 71, 1 (32-40)), The Journal of Clinical Psychiatry, vol. 72 no. 8 (August, 2011), pp. 1157, ISSN 0160-6689 [doi]
  102. Krystal, AD, Recognition and assessment of shift work disorder., The Journal of Clinical Psychiatry, vol. 72 no. 2 (February, 2011), pp. 248-257, Physicians Postgraduate Press, Inc, ISSN 0160-6689 [doi]  [abs]
  103. Richey, SM; Krystal, AD, Pharmacological advances in the treatment of insomnia., Curr Pharm Des, vol. 17 no. 15 (2011), pp. 1471-1475 [21476952], [doi]  [abs]
  104. Krystal, AD, Antidepressant and Antipsychotic Drugs., Sleep Med Clin, vol. 5 no. 4 (December, 2010), pp. 571-589, ISSN 1556-407X [21499530], [doi]
  105. Krystal, AD; Durrence, HH; Scharf, M; Jochelson, P; Rogowski, R; Ludington, E; Roth, T, Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia., Sleep, vol. 33 no. 11 (November, 2010), pp. 1553-1561, ISSN 0161-8105 [21102997], [doi]  [abs]
  106. Wilson, SJ; Nutt, DJ; Alford, C; Argyropoulos, SV; Baldwin, DS; Bateson, AN; Britton, TC; Crowe, C; Dijk, D-J; Espie, CA; Gringras, P; Hajak, G; Idzikowski, C; Krystal, AD; Nash, JR; Selsick, H; Sharpley, AL; Wade, AG, British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders., J Psychopharmacol, vol. 24 no. 11 (November, 2010), pp. 1577-1601 [20813762], [doi]  [abs]
  107. Janicak, PG; Nahas, Z; Lisanby, SH; Solvason, HB; Sampson, SM; McDonald, WM; Marangell, LB; Rosenquist, P; McCall, WV; Kimball, J; O'Reardon, JP; Loo, C; Husain, MH; Krystal, A; Gilmer, W; Dowd, SM; Demitrack, MA; Schatzberg, AF, Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study., Brain Stimul, vol. 3 no. 4 (October, 2010), pp. 187-199, ISSN 1935-861X [20965447], [doi]  [abs]
  108. Flynn, KE; Shelby, RA; Mitchell, SA; Fawzy, MR; Hardy, NC; Husain, AM; Keefe, FJ; Krystal, AD; Porter, LS; Reeve, BB; Weinfurt, KP, Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®))., Psycho Oncology, vol. 19 no. 10 (October, 2010), pp. 1086-1093 [20013938], [doi]  [abs]
  109. McCall, WV; Blocker, JN; D'Agostino, R; Kimball, J; Boggs, N; Lasater, B; Haskett, R; Krystal, A; McDonald, WM; Rosenquist, PB, Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 6 no. 4 (August, 2010), pp. 322-329, ISSN 1550-9389  [abs]
  110. Krystal, AD; Zammit, GK; Wyatt, JK; Quan, SF; Edinger, JD; White, DP; Chiacchierini, RP; Malhotra, A, The effect of vestibular stimulation in a four-hour sleep phase advance model of transient insomnia., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 6 no. 4 (August, 2010), pp. 315-321, ISSN 1550-9389 [20726278]  [abs]
  111. Krystal, AD; Preud'homme, XA; Amundsen, CL; Webster, GD, Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study., The Journal of Urology, vol. 184 no. 2 (August, 2010), pp. 623-628 [20639027], [doi]  [abs]
  112. Krystal, AD, In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications., Sleep, vol. 33 no. 7 (July, 2010), pp. 859-860, ISSN 0161-8105 [20614842], [doi]
  113. Krystal, AD; Edinger, JD, Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia., Sleep, vol. 33 no. 5 (May, 2010), pp. 669-677, ISSN 0161-8105 [20469809], [doi]  [abs]
  114. Ancoli-Lsrael, S; Krystal, AD, Insomnia: A health care (gap that is growing), Psychiatric Times, vol. 27 no. SUPPL. APRIL (April, 2010), pp. 1-4, ISSN 0893-2905  [abs]
  115. Ohayon, MM; Krystal, A; Roehrs, TA; Roth, T; Vitiello, MV, Using difficulty resuming sleep to define nocturnal awakenings., Sleep Med, vol. 11 no. 3 (March, 2010), pp. 236-241, ISSN 1389-9457 [doi]  [abs]
  116. Ancoli-Israel, S; Krystal, AD; McCall, WV; Schaefer, K; Wilson, A; Claus, R; Rubens, R; Roth, T, A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia., Sleep, vol. 33 no. 2 (February, 2010), pp. 225-234, ISSN 0161-8105 [20175406], [doi]  [abs]
  117. Krystal, AD; Harsh, JR; Yang, R; Rippon, GA; Lankford, DA, A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression., The Journal of Clinical Psychiatry, vol. 71 no. 1 (January, 2010), pp. 32-40 [20051221], [doi]  [abs]
  118. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, AA; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, UTILITY, VALIDITY, AND METHODOLOGICAL FACTORS INFLUENCING ASSIGNMENT OF DSM-IV-TR INSOMNIA DIAGNOSES: CONSIDERATIONS FOR DSM-V, Sleep, vol. 33 (January, 2010), pp. A191-A191, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  119. Edinger, JD; Green, MR; Prather, AA; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, AA; Krystal, AD; Radtke, RA, VALIDITY AND RELIABILITY OF THE DSM-IV-TR AND ICSD-2 INSOMNIA NOSOLOGIES AMONG CAUCASIANS AND AFRICAN-AMERICANS, Sleep, vol. 33 (January, 2010), pp. A209-A209, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  120. Preud'homme, XA; Amundsen, CL; Webster, GD; Krystal, AD, MONITORED NIGHTTIME BLADDER FUNCTION: COMPARISONS BETWEEN PATIENTS WITH INSOMNIA AND THOSE WITH OVERACTIVE BLADDER SYNDROME, Sleep, vol. 33 (January, 2010), pp. A293-A293, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  121. Preud'homme, XA; Amundsen, CL; Webster, GD; Krystal, AD, SELF-REPORTED SLEEP: HOW DO PATIENTS WITH OAB COMPARE TO INSOMNIACS AND NORMAL SUBJECTS?, Sleep, vol. 33 (January, 2010), pp. A292-A292, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  122. Krystal, AD; Preud'homme, XA; Amundsen, CL; Webster, GD, NOCTURNAL DETRUSOR OVERACTIVITY IN OVERACTIVE BLADDER SYNDROME: A NOCTURNAL CYSTOMETROGRAPHIC AND POLYSOMNOGRAPHIC STUDY, Sleep, vol. 33 (January, 2010), pp. A293-A293, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  123. Krystal, AD; Harsh, J; Yang, R; Rippon, GA; Lankford, A, EFFECT OF ARMODAFINIL ON PATIENT FUNCTIONING AND FATIGUE: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY IN PATIENTS WITH RESIDUAL EXCESSIVE SLEEPINESS ASSOCIATED WITH TREATED OBSTRUCTIVE SLEEP APNEA AND A COMORBID DEPRESSIVE DISORDER, Sleep, vol. 33 (January, 2010), pp. A7-A8, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  124. Low, Y; Omonuwa, T; Goforth, HW; Krystal, AD, INSOMNIA SEVERITY IN HIV-SEROPOSITIVE PATIENTS IS ASSOCIATED WITH INCREASED FATIGUE, Sleep, vol. 33 (January, 2010), pp. A194-A194, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  125. Low, Y; Suarez, EC; Omonuwa, T; Goforth, HW; Krystal, AD, A PILOT STUDY: IMPROVEMENT IN INSOMNIA SEVERITY IS ASSOCIATED WITH DECREASED SOLUBLE CD4-LIGAND IN HIV-SEROPOSITIVE PATIENTS, Sleep, vol. 33 (January, 2010), pp. A26-A27, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  126. Krystal, AD, THE TREATMENT OF PRIMARY INSOMNIA, Cns Spectrums, vol. 14 no. 12 (December, 2009), pp. 6-10, ISSN 1092-8529 [20448512], [doi]
  127. Krystal, AD, A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice., Sleep Med Rev, vol. 13 no. 4 (August, 2009), pp. 265-274 [19153052], [doi]  [abs]
  128. Omonuwa, TS; Goforth, HW; Preud'homme, X; Krystal, AD, The pharmacologic management of insomnia in patients with HIV., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 5 no. 3 (June, 2009), pp. 251-262, ISSN 1550-9389 [19960648]  [abs]
  129. Carney, CE; Ulmer, C; Edinger, JD; Krystal, AD; Knauss, F, Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II)., Journal of Psychiatric Research, vol. 43 no. 5 (February, 2009), pp. 576-582, ISSN 0022-3956 [18954876], [doi]  [abs]
  130. Lisanby, SH; Husain, MM; Rosenquist, PB; Maixner, D; Gutierrez, R; Krystal, A; Gilmer, W; Marangell, LB; Aaronson, S; Daskalakis, ZJ; Canterbury, R; Richelson, E; Sackeim, HA; George, MS, Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial., Neuropsychopharmacology, vol. 34 no. 2 (January, 2009), pp. 522-534 [18704101], [doi]  [abs]
  131. Carney, CE; Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Chiang, A; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, SHOULD DSM-IV-TR PRIMARY INSOMNIA BE DIVIDED INTO SPECIFIC SUBTYPES?, Sleep, vol. 32 (January, 2009), pp. A264-A265, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  132. Sutherland, ME; Edinger, JD; Carney, C; Preud'homme, X; Krystal, AD, EFFECTS OF MANUAL ARTIFACT-REJECTION ON NON-REM SLEEP EEG SPECTRAL ANALYSIS, Sleep, vol. 32 (January, 2009), pp. A374-A374, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  133. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, RELIABILITY AND VALIDITY OF THE DUKE STRUCTURED INTERVIEW FOR SLEEP DISORDERS FOR INSOMNIA SCREENING, Sleep, vol. 32 (January, 2009), pp. A265-A265, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  134. Kane, JM; Krystal, AD; McKenzie, JE; Yang, R; Tiller, J; Youakim, JM, SLEEP IN SCHIZOPHRENIA: A NIGHT- AND DAYTIME ACTIGRAPHY STUDY IN PATIENTS WITH TREATED WITH ORAL RISPERIDONE, OLANZAPINE OR PALIPERIDONE, Sleep, vol. 32 (January, 2009), pp. A355-A355, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  135. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Krystal, AD; Lineberger, MD; Means, MK; Radtke, RA, COMPARATIVE VALIDITY OF THE DSM-IV-TR AND ICSD-2 INSOMNIA NOSOLOGIES: HOW MANY WAYS SHOULD WE SLICE THE INSOMNIA PIE?, Sleep, vol. 32 (January, 2009), pp. A263-A263, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  136. Preud'homme, XA; Lanquart, J-P; Krystal, AD; Bogaerts, P; Linkowski, P, Modeling slow-wave activity dynamics: does an exponentially dampened periodic function really fit a single night of normal human sleep?, Clin Neurophysiol, vol. 119 no. 12 (December, 2008), pp. 2753-2761 [18986831], [doi]  [abs]
  137. Krystal, AD; Edinger, JD, Measuring sleep quality., Sleep Med, vol. 9 Suppl 1 (September, 2008), pp. S10-S17 [18929313], [doi]  [abs]
  138. Krystal, AD, Non-REM sleep EEG spectral analysis in insomnia, Psychiatric Annals, vol. 38 no. 9 (September, 2008), pp. 615-620, ISSN 0048-5713  [abs]
  139. Krystal, AD; Goforth, HW; Roth, T, Effects of antipsychotic medications on sleep in schizophrenia., International Clinical Psychopharmacology, vol. 23 no. 3 (May, 2008), pp. 150-160, ISSN 0268-1315 [18408529], [doi]  [abs]
  140. Pollack, M; Kinrys, G; Krystal, A; McCall, WV; Roth, T; Schaefer, K; Rubens, R; Roach, J; Huang, H; Krishnan, R, Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder., Arch Gen Psychiatry, vol. 65 no. 5 (May, 2008), pp. 551-562, ISSN 0003-990X [doi]  [abs]
  141. Edinger, JD; Means, MK; Carney, CE; Krystal, AD, Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia., Sleep, vol. 31 no. 5 (May, 2008), pp. 599-607, ISSN 0161-8105 [18517030], [doi]  [abs]
  142. Krystal, JH; Carter, CS; Geschwind, D; Manji, HK; March, JS; Nestler, EJ; Zubieta, J-K; Charney, DS; Goldman, D; Gur, RE; Lieberman, JA; Roy-Byrne, P; Rubinow, DR; Anderson, SA; Barondes, S; Berman, KF; Blair, J; Braff, DL; Brown, ES; Calabrese, JR; Carlezon, WA; Cook, EH; Davidson, RJ; Davis, M; Desimone, R; Drevets, WC; Duman, RS; Essock, SM; Faraone, SV; Freedman, R; Friston, KJ; Gelernter, J; Geller, B; Gill, M; Gould, E; Grace, AA; Grillon, C; Gueorguieva, R; Hariri, AR; Innis, RB; Jones, EG; Kleinman, JE; Koob, GF; Krystal, AD; Leibenluft, E; Levinson, DF; Levitt, PR; Lewis, DA; Liberzon, I; Lipska, BK; Marder, SR; Markou, A; Mason, GF; McDougle, CJ; McEwen, BS; McMahon, FJ; Meaney, MJ; Meltzer, HY; Merikangas, KR; Meyer-Lindenberg, A; Mirnics, K; Monteggia, LM; Neumeister, A; O'Brien, CP; Owen, MJ; Pine, DS; Rapoport, JL; Rauch, SL; Robbins, TW; Rosenbaum, JF; Rosenberg, DR; Ross, CA; Rush, AJ; Sackeim, HA; Sanacora, G; Schatzberg, AF; Shaham, Y; Siever, LJ; Sunderland, T; Tecott, LH; Thase, ME; Todd, RD; Weissman, MM; Yehuda, R; Yoshikawa, T; Young, EA; McCandless, R, It is time to take a stand for medical research and against terrorism targeting medical scientists., Biol Psychiatry, vol. 63 no. 8 (April, 2008), pp. 725-727, ISSN 0006-3223 [18371494], [doi]
  143. Chiang, A; Krystal, A, Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 4 no. 2 (April, 2008), pp. 155-156, ISSN 1550-9389  [abs]
  144. Krystal, AD; Erman, M; Zammit, GK; Soubrane, C; Roth, T; ZOLONG Study Group,, Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study., Sleep, vol. 31 no. 1 (January, 2008), pp. 79-90, ISSN 0161-8105 [18220081], [doi]  [abs]
  145. Krystal, AD; Thakur, M; Roth, T, Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia., Ann Clin Psychiatry, vol. 20 no. 1 (January, 2008), pp. 39-46 [18297585], [doi]  [abs]
  146. Brummett, BH; Krystal, AD; Ashley-Koch, A; Kuhn, CM; Züchner, S; Siegler, IC; Barefoot, JC; Ballard, EL; Gwyther, LP; Williams, RB, Sleep quality varies as a function of 5-HTTLPR genotype and stress., Psychosom Med, vol. 69 no. 7 (September, 2007), pp. 621-624 [17766685], [doi]  [abs]
  147. Walsh, JK; Krystal, AD; Amato, DA; Rubens, R; Caron, J; Wessel, TC; Schaefer, K; Roach, J; Wallenstein, G; Roth, T, Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations., Sleep, vol. 30 no. 8 (August, 2007), pp. 959-968, ISSN 0161-8105 [17702264], [doi]  [abs]
  148. Roth, T; Krystal, AD; Lieberman, JA, Long-term issues in the treatment of sleep disorders, Primary Psychiatry, vol. 14 no. 7 (July, 2007), pp. 1-14, ISSN 1082-6319  [abs]
  149. Roth, T; Krystal, AD; Lieberman, JA, Long-term issues in the treatment of sleep disorders., Cns Spectrums, vol. 12 no. 7 Suppl 10 (July, 2007), pp. 1-14, ISSN 1092-8529 [17603408]  [abs]
  150. Lim, L; Krystal, A, Psychotic disorder in a patient with central and extrapontine myelinolysis., Psychiatry and Clinical Neurosciences, vol. 61 no. 3 (June, 2007), pp. 320-322, ISSN 1323-1316 [doi]  [abs]
  151. Brummett, BH; Krystal, AD; Siegler, IC; Kuhn, C; Surwit, RS; Züchner, S; Ashley-Koch, A; Barefoot, JC; Williams, RB, Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality., Psychosom Med, vol. 69 no. 5 (June, 2007), pp. 396-401 [17585061], [doi]  [abs]
  152. Krystal, AD; Thase, ME; Tucker, VL; Goodale, EP, Bupropion HCL and sleep in patients with depression, Current Psychiatry Reviews, vol. 3 no. 2 (May, 2007), pp. 123-128, Bentham Science Publishers Ltd., ISSN 1573-4005 [doi]  [abs]
  153. Krystal, AD; Davidson, JRT, The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder., Biological Psychiatry, vol. 61 no. 8 (April, 2007), pp. 925-927, ISSN 0006-3223 [17397667], [doi]
  154. Krystal, A; Fava, M; Rubens, R; Wessel, T; Caron, J; Wilson, P; Roth, T; McCall, WV, Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 3 no. 1 (February, 2007), pp. 48-55, ISSN 1550-9389  [abs]
  155. Krystal, AD, Treating the health, quality of life, and functional impairments in insomnia., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 3 no. 1 (February, 2007), pp. 63-72, ISSN 1550-9389 [17557457]  [abs]
  156. Carney, CE; Segal, ZV; Edinger, JD; Krystal, AD, A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder., The Journal of Clinical Psychiatry, vol. 68 no. 2 (February, 2007), pp. 254-260 [17335324]  [abs]
  157. Krystal, AD, The Morbidity of Insomnia, Cns Spectrums, vol. 12 no. S10 (January, 2007), pp. 6-8, Cambridge University Press (CUP) [doi]  [abs]
  158. Krystal, AD, Sleep and psychiatric disorders: future directions., The Psychiatric Clinics of North America, vol. 29 no. 4 (December, 2006), pp. 1115-1130, ISSN 0193-953X [17118285], [doi]  [abs]
  159. Zammit, GK; Corser, B; Doghramji, K; Fry, JM; James, S; Krystal, A; Mangano, RM, Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 2 no. 4 (October, 2006), pp. 417-423, ISSN 1550-9389  [abs]
  160. Krystal, AD; Rogers, S; Fitzgerald, MA, Long-Term Pharmacotherapy in the Management of Chronic Insomnia, The Journal for Nurse Practitioners, vol. 2 no. 9 (October, 2006), pp. S621-S632, Elsevier BV, ISSN 1555-4155 [doi]  [abs]
  161. McCall, WV; Erman, M; Krystal, AD; Rosenberg, R; Scharf, M; Zammit, GK; Wessel, T, A polysomnography study of eszopiclone in elderly patients with insomnia., Current Medical Research and Opinion, vol. 22 no. 9 (September, 2006), pp. 1633-1642, ISSN 0300-7995 [16968566], [doi]  [abs]
  162. Krystal, AD, Psychiatric Comorbidity: The Case for Treating Insomnia, Sleep Medicine Clinics, vol. 1 no. 3 (September, 2006), pp. 359-365, Elsevier BV, ISSN 1556-407X [doi]  [abs]
  163. Fava, M; McCall, WV; Krystal, A; Wessel, T; Rubens, R; Caron, J; Amato, D; Roth, T, Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder., Biological Psychiatry, vol. 59 no. 11 (June, 2006), pp. 1052-1060, ISSN 0006-3223 [doi]  [abs]
  164. Walsh, JK; Perlis, M; Rosenthal, M; Krystal, A; Jiang, J; Roth, T, Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 2 no. 1 (January, 2006), pp. 35-41, ISSN 1550-9389  [abs]
  165. Ancoli-Israel, S; Folks, DG; Krystal, AD; McCall, WV, Response to Dr. Finucane [2], Journal of the American Geriatrics Society, vol. 54 no. 1 (January, 2006), pp. 170-172, WILEY, ISSN 0002-8614 [doi]
  166. Ancoli-Israel, S; Folks, DG; Krystal, AD; McCall, WV, Advertising the new hypnotics - Response to Dr. Finucane, Journal of the American Geriatrics Society, vol. 54 no. 1 (January, 2006), pp. 170-172, BLACKWELL PUBLISHING, ISSN 0002-8614 [Gateway.cgi]
  167. Edinger, JD; Wohlgemuth, WK; Krystal, AD; Rice, JR, Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial., Archives of Internal Medicine, vol. 165 no. 21 (November, 2005), pp. 2527-2535, ISSN 0003-9926 [16314551], [doi]  [abs]
  168. Roth, T; Walsh, JK; Krystal, A; Wessel, T; Roehrs, TA, An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia., Sleep Medicine, vol. 6 no. 6 (November, 2005), pp. 487-495, ISSN 1389-9457 [doi]  [abs]
  169. Krystal, AD, The effect of insomnia definitions, terminology, and classifications on clinical practice., Journal of the American Geriatrics Society, vol. 53 no. 7 Suppl (July, 2005), pp. S258-S263, ISSN 0002-8614 [15982374], [doi]  [abs]
  170. Wohlgemuth, WK; Krystal, AD, Hypnotics should be considered for the initial treatment of chronic insomnia. Pro., Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine, vol. 1 no. 2 (April, 2005), pp. 120-124, ISSN 1550-9389 [17561623]
  171. Krystal, AD, The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep., Sleep, vol. 28 no. 1 (January, 2005), pp. 16-17, ISSN 0161-8105 [15700715]
  172. McCall, WV; Perlis, ML; Tu, X; Groman, AE; Krystal, A; Walsh, JK, A comparison of placebo and no-treatment during a hypnotic clinical trial, International Journal of Clinical Pharmacology and Therapeutics, vol. 43 no. 8 (2005), pp. 355-359, Dustri-Verlgag Dr. Karl Feistle, ISSN 0946-1965 [doi]  [abs]
  173. Krystal, AD; Roth, T, Definitions, measurements, and management in insomnia, The Journal of Clinical Psychiatry, vol. 65 no. SUPPL. 8 (December, 2004), pp. 5-7, ISSN 0160-6689
  174. Perlis, ML; McCall, WV; Krystal, AD; Walsh, JK, Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia., The Journal of Clinical Psychiatry, vol. 65 no. 8 (August, 2004), pp. 1128-1137, ISSN 0160-6689 [15323600]  [abs]
  175. Singh, J; Zarate, CA; Krystal, AD, Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine., Psychopharmacology, vol. 173 no. 1-2 (April, 2004), pp. 227-228, ISSN 0033-3158 [14722708], [doi]
  176. Krystal, AD; Walsh, JK; Laska, E; Caron, J; Amato, DA; Wessel, TC; Roth, T, The Sustained 6-Month Efficacy of Eszopiclone in the Treatment of Chronic Insomnia, Sleep, vol. 27 no. 2 (March, 2004), pp. 346-347, Oxford University Press (OUP), ISSN 0161-8105 [Gateway.cgi], [doi]
  177. Ancoli-Israel, S; Benca, RM; Edinger, JD; Krystal, AD; Mendelson, W; Moldofsky, H; Petrie, J; Roth, T; Walsh, JK; Winkelman, J, Changing how we think about insomnia, The Journal of Clinical Psychiatry, vol. 65 (January, 2004), pp. 44-46, PHYSICIANS POSTGRADUATE PRESS, ISSN 0160-6689 [Gateway.cgi]
  178. Krystal, AD, Depression and insomnia in women., Clinical Cornerstone, vol. 6 Suppl 1B (2004), pp. S19-S28, ISSN 1098-3597 [15457812], [doi]  [abs]
  179. Krystal, AD; Roth, T, Introduction: Definitions, measurements, and management in insomnia., The Journal of Clinical Psychiatry, vol. 65 Suppl 8 (2004), pp. 5-7, ISSN 0160-6689 [15153061]
  180. Krystal, AD, The changing perspective on chronic insomnia management., The Journal of Clinical Psychiatry, vol. 65 Suppl 8 (2004), pp. 20-25, ISSN 0160-6689 [15153064]  [abs]
  181. Ancoli-Israel, S; Benca, RM; Edinger, JD; Krystal, AD; Mendelson, W; Moldofsky, H; Petrie, J; Roth, T; Walsh, JK; Winkelman, J; Special Issues Board Panel Members,, Panel discussion: changing how we think about insomnia., The Journal of Clinical Psychiatry, vol. 65 Suppl 8 (2004), pp. 44-46, ISSN 0160-6689 [15153067]
  182. Krystal, AD; Walsh, JK; Laska, E; Caron, J; Amato, DA; Wessel, TC; Roth, T, Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia., Sleep, vol. 26 no. 7 (November, 2003), pp. 793-799, ISSN 0161-8105 [14655910], [doi]  [abs]
  183. Edinger, JD; Krystal, AD, Subtyping primary insomnia: is sleep state misperception a distinct clinical entity?, Sleep Medicine Reviews, vol. 7 no. 3 (June, 2003), pp. 203-214, ISSN 1087-0792 [12927120], [doi]  [abs]
  184. Cellucci, CJ; Albano, AM; Rapp, PE; Krystal, AD, Quantitative determination of abrupt changes in dynamical systems: Illustration via identification of seizure termination in generalized tonic-clonic seizure EEG data, International Journal of Bifurcation and Chaos, vol. 13 no. 9 (January, 2003), pp. 2641-2655, World Scientific Pub Co Pte Lt [doi]  [abs]
  185. Krystal, AD, Insomnia in women., Clinical Cornerstone, vol. 5 no. 3 (2003), pp. 41-50, ISSN 1098-3597 [14626540], [doi]  [abs]
  186. Krystal, AD; Weiner, RD; Dean, MD; Lindahl, VH; Tramontozzi, LA; Falcone, G; Coffey, CE, Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 15 no. 1 (2003), pp. 27-34, ISSN 0895-0172 [12556568], [doi]  [abs]
  187. Krystal, AD; Edinger, JD; Wohlgemuth, WK; Marsh, GR, NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes., Sleep, vol. 25 no. 6 (September, 2002), pp. 630-640, ISSN 0161-8105 [12224842]  [abs]
  188. Wohlgemuth, WK; Edinger, JD; Krystal, AD, The best of both: Brief hypnotic use to enhance behavioral insomnia therapy, Sleep, vol. 25 (April, 2002), pp. A360-A361, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  189. Wohlgemuth, WK; Edinger, JD; Krystal, AD; Rice, JR, Behavioral insomnia therapy for patients with fibromyalgia, Sleep, vol. 25 (April, 2002), pp. A384-A384, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  190. Krystal, AD; Edinger, JD; Wohlgemuth, WK; Michaels, C, A within-subject study of the relationship of non-REM EEG spectral amplitude and the agreement between subjective and objective assessments of sleep time, Sleep, vol. 25 (April, 2002), pp. A33-A34, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  191. Krystal, AD; Perlis, ML; McCall, WV; Zammit, G; Hirshkowitz, M, Three-month non-nightly use of zolpidem for the treatment of primary insomnia, Sleep, vol. 25 (April, 2002), pp. A68-A68, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  192. Rossler, IB; Johnson, RC; Krystal, AD; Weiner, RD; Levin, ED; Logue, P; Coffey, CE; Edwards, CL, A naturalistic study of the effects of smoking on the cognitive side effects of ECT., The Journal of Ect, vol. 18 no. 1 (March, 2002), pp. 64-64, LIPPINCOTT WILLIAMS & WILKINS, ISSN 1095-0680 [Gateway.cgi]
  193. Vidal, F; Krystal, AD; Edinger, JD; Wohlgemuth, WK, Changes in sleep architecture and the sleep EEG with aging., American Journal of Geriatric Psychiatry, vol. 10 no. 2 (March, 2002), pp. 96-97, AMER PSYCHIATRIC PRESS, INC, ISSN 1064-7481 [Gateway.cgi]
  194. Krystal, AD; Ressler, I, The use of valerian in neuropsychiatry., Cns Spectrums, vol. 6 no. 10 (October, 2001), pp. 841-847, ISSN 1092-8529 [15334039], [doi]  [abs]
  195. Sackeim, HA; Devanand, DP; Lisanby, SH; Nobler, MS; Prudic, J; Heyer, EJ; Ornstein, E; Weiner, RD; Krystal, AD; Coffey, CE; Greenberg, RM; Husain, M; Lite, MS; Fernandez, P; Gaines, GY, Treatment of the modal patient: does one size fit nearly all?, The Journal of Ect, vol. 17 no. 3 (September, 2001), pp. 219-222, ISSN 1095-0680 [11528317], [doi]
  196. Swartz, CM, ECT failure rate among specific devices., The American Journal of Psychiatry, vol. 158 no. 6 (June, 2001), pp. 973-974 [doi]
  197. Krystal, AD; Weiner, RD, ECT failure rate among specific devices - Drs. Krystal and Weiner reply, The American Journal of Psychiatry, vol. 158 no. 6 (June, 2001), pp. 974-974, AMER PSYCHIATRIC PRESS, INC, ISSN 0002-953X [Gateway.cgi]
  198. Krystal, AD; Edinger, JD; Wohlgemuth, WK; Marsh, GR, A pilot study of the sleep EEG power spectral effects of behavioral therapy in primary insomniacs, Sleep, vol. 24 (April, 2001), pp. A62-A62, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  199. Krystal, AD; Holsinger, T; Weiner, RD; Steffens, DC; Coffey, CE, A naturalistic study of maintenance ECT: Implications for optimizing the inter-treatment interval., The Journal of Ect, vol. 17 no. 1 (March, 2001), pp. 79-79, LIPPINCOTT WILLIAMS & WILKINS, ISSN 1095-0680 [Gateway.cgi]
  200. Prado, R; West, M; Krystal, AD, Multichannel electroencephalographic analyses via dynamic regression models with time-varying lag-lead structure, Journal of the Royal Statistical Society. Series C, Applied Statistics, vol. 50 no. 1 (January, 2001), pp. 95-109 [doi]  [abs]
  201. Prado R, West M, Krystal AD  Multichannel electroencephalographic analyses via dynamic regression models with time-varying lag-lead structure J. Royal Statistical Society C-APP Part I. 2001;50: 95-109.
  202. Krystal, AD; Holsinger, T; Weiner, RD; Coffey, CE, Prediction of the utility of a switch from unilateral to bilateral ECT in the elderly using treatment 2 ictal EEG indices., The Journal of Ect, vol. 16 no. 4 (December, 2000), pp. 327-337, ISSN 1095-0680 [11314870], [doi]  [abs]
  203. Krystal, AD; Weiner, RD; Lindahl, V; Massie, R, The development and retrospective testing of an electroencephalographic seizure quality-based stimulus dosing paradigm with ECT., The Journal of Ect, vol. 16 no. 4 (December, 2000), pp. 338-349, ISSN 1095-0680 [11314871], [doi]  [abs]
  204. Krystal, AD; Dean, MD; Weiner, RD; Tramontozzi, LA; Connor, KM; Lindahl, VH; Massie, RW, ECT stimulus intensity: are present ECT devices too limited?, The American Journal of Psychiatry, vol. 157 no. 6 (June, 2000), pp. 963-967, ISSN 0002-953X [10831477], [doi]  [abs]
  205. Krystal, AD; Weiner, RD; Luber, B; Prudic, J; Devanand, DP; Sackeim, HA, The role of the ictal EEG in ECT stimulus dosing., The Journal of Ect, vol. 16 no. 1 (March, 2000), pp. 74-74, LIPPINCOTT WILLIAMS & WILKINS, ISSN 1095-0680 [Gateway.cgi]
  206. Zoldi, SM; Krystal, A; Greenside, HS, Stationarity and redundancy of multichannel EEG data recorded during generalized tonic-clonic seizures., Brain Topography, vol. 12 no. 3 (2000), pp. 187-200, ISSN 0896-0267 [10791682], [doi]  [abs]
  207. Krystal, AD; West, M; Prado, R; Greenside, H; Zoldi, S; Weiner, RD, EEG effects of ECT: implications for rTMS., Depression and Anxiety, vol. 12 no. 3 (2000), pp. 157-165, ISSN 1091-4269 [11126190], [doi]  [abs]
  208. West, M; Prado, R; Krystal, AD, Evaluation and Comparison of EEG Traces: Latent Structure in Nonstationary Time Series, Journal of the American Statistical Association, vol. 94 no. 448 (December, 1999), pp. 1083-1095, Informa UK Limited, ISSN 0162-1459 [doi]  [abs]
  209. Krystal, AD; Prado, R; West, M, New methods of time series analysis of non-stationary EEG data: eigenstructure decompositions of time varying autoregressions., Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology, vol. 110 no. 12 (December, 1999), pp. 2197-2206, ISSN 1388-2457 [10616127], [doi]  [abs]
  210. Asnis, GM; Chakraburtty, A; DuBoff, EA; Krystal, A; Londborg, PD; Rosenberg, R; Roth-Schechter, B; Scharf, MB; Walsh, JK, Zolpidem for persistent insomnia in SSRI-treated depressed patients., The Journal of Clinical Psychiatry, vol. 60 no. 10 (October, 1999), pp. 668-676, ISSN 0160-6689 [10549683]  [abs]
  211. West, M; Prado, R; Krystal, AD, Evaluation and Comparison of EEG Traces: Latent Structure in Nonstationary Time Series, Journal of the American Statistical Association, vol. 94 no. 446 (June, 1999), pp. 375-387, Informa UK Limited, ISSN 0162-1459 [doi]  [abs]
  212. Krystal, AD; Weiner, RD, EEG correlates of the response to ECT: a possible antidepressant role of brain-derived neurotrophic factor., The Journal of Ect, vol. 15 no. 1 (March, 1999), pp. 27-38, ISSN 1095-0680 [10189617]  [abs]
  213. Weiner, RD; Krystal, AD, 2. ECT and Anticonvulsant Medications, The Journal of Ect, vol. 15 no. 1 (March, 1999), pp. 104-104, Ovid Technologies (Wolters Kluwer Health), ISSN 1095-0680 [Gateway.cgi], [doi]
  214. Krystal, AD; Weiner, RD; R. Krishnan, KR, 3. Magnetic Resonance Spectroscopic Correlates of the Response to ECT, The Journal of Ect, vol. 15 no. 1 (March, 1999), pp. 103-103, Ovid Technologies (Wolters Kluwer Health), ISSN 1095-0680 [Gateway.cgi], [doi]
  215. West, M. Prado, R. and Krystal, A.  Evaluation and comparison of EEG traces: Latent structure in non-staionary time series.  Journal of the American Statistical Association, 94:375-387, 1999.
  216. Krystal, AD; Edinger, J; Wohlgemuth, W; Marsh, GR, Sleep in peri-menopausal and post-menopausal women., Sleep Medicine Reviews, vol. 2 no. 4 (November, 1998), pp. 243-253, ISSN 1087-0792 [15310495], [doi]  [abs]
  217. Krystal, AD; Greenside, HS; Gottschalk, A; Bauer, MS; Whybrow, PC, Low-dimensional chaos in bipolar disorder [1] (multiple letters), Archives of Internal Medicine, vol. 158 no. 5 (March, 1998), pp. 275, ISSN 0003-990X [doi]
  218. Krystal, AD; Greenside, HS, Low-dimensional chaos in bipolar disorder?, Archives of General Psychiatry, vol. 55 no. 3 (March, 1998), pp. 275-276, ISSN 0003-990X [9510223], [doi]
  219. Krystal, AD; Watts, BV; Weiner, RD; Moore, S; Steffens, DC; Lindahl, V, The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient., The Journal of Ect, vol. 14 no. 1 (March, 1998), pp. 5-14, ISSN 1095-0680 [9661088]  [abs]
  220. Krystal, AD, The clinical utility of ictal EEG seizure adequacy models, Psychiatric Annals, vol. 28 no. 1 (January, 1998), pp. 30-35, SLACK INC [doi]
  221. Krystal, A.D., (member of the U.S. Modafinil in Narcolepsy Study Group). HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. Tissue Antigens 51:96-100, 1998.
  222. Weiner, R.D., Krystal, A.D. The cognitive side-effects of ECT. Progress in Neuro- Psychopharmacology & Biological Psychiatry, in press.
  223. Krystal AD. The clinical utility of ictal EEG seizure adequacy models. Psychiatric Annals 1:30- 35, 1998.
  224. Krystal, A.D., (member of the U.S. Modafinil in Narcolepsy Study Group). Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Annals of Neurology 43:88-97, 1998.
  225. Krystal, A.D., Edinger, J., Wohlgemuth, W., Marsh, G.R. Sleep in peri-menopausal and post- menopausal women. Sleep Medicine Reviews, 2:243-253, 1998.
  226. West, M., Prado, R., Krystal, A.D. Evaluation and comparison of EEG traces: Latent structure in non-stationary time series. Journal of the American Statistical Association, in press.
  227. Krystal, A.D., Zoldi, S., Greenside, H., Prado, R., West, M., Weiner, R. The effects of ECT on the EEG: implicatons for rTMS. Progress in Neuro-Psychopharmacology & Biological Psychiatry, in press.
  228. Weiner RD, Coffey CE and Krystal AD. Electroconvulsive therapy in the medical and neurological patient. 2nd edition. IN: Psychiatric Care of the Medical Patient. (Stoudemire A, Fogel BS, Eds.), New York, Oxford University Press, in press.
  229. Krystal, A.D., Zoldi, S., Prado, R., Greenside, H.S., West, M. The spatiotemporal dynamics of generalized tonic-clonic seizure EEG data: Relevance to the clinical practice of electroconvulsive therapy. IN: Proceedings of the International Conference on Nonlinear Dynamics and Brain Functioning (Rapp, P., Ed.). In Press.
  230. Krystal, AD; Coffey, CE; Weiner, RD; Holsinger, T, Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 10 no. 2 (1998), pp. 178-186, ISSN 0895-0172 [9608406], [doi]  [abs]
  231. Krystal, AD; Zaidman, C; Greenside, HS; Weiner, RD; Coffey, CE, The largest Lyapunov exponent of the EEG during ECT seizures as a measure of ECT seizure adequacy., Electroencephalography and Clinical Neurophysiology, vol. 103 no. 6 (December, 1997), pp. 599-606, ISSN 0013-4694 [9546486], [doi]  [abs]
  232. Krystal, AD; Coffey, CE; Weiner, RD; Rapp, PE; Albano, A; Greenside, HS; DeMasi, M; Cellucci, C, EEG correlates of the response to ECT, Biological Psychiatry, vol. 41 (April, 1997), pp. 189-189, ELSEVIER SCIENCE INC, ISSN 0006-3223 [Gateway.cgi]
  233. Krystal, AD; Weiner, RD; Watts, BV; Moore, S; Steffens, DC; Lindahl, V, The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient., Convulsive Therapy, vol. 13 no. 1 (March, 1997), pp. 57-58, LIPPINCOTT-RAVEN PUBL
  234. Weiner, RD; Krystal, AD; Steffens, DC, Establishing an ambulatory ECT program: Different models., Convulsive Therapy, vol. 13 no. 1 (March, 1997), pp. 49-49, LIPPINCOTT-RAVEN PUBL, ISSN 0749-8055 [Gateway.cgi]
  235. Krystal, A.D., Watts, B.V., Weiner, R.D., Moore, S., Steffens, D., Lindahl, V. The use of flumazenil in the anxious and benzodiazepine dependent ECT patient. Convulsive Therapy 13(4)xx-xx, 1997.
  236. Edinger, J.D., Fins, A.I., Goeke, J.M., McMillan, D.K., Gersh, T.L., Krystal, A.D., McCall, W.V. The empirical identification of insomnia subtypes: A cluster analytic approach. Sleep (in press).
  237. Krystal, A.D., Weiner, R.D., Lindahl, V, Massie, R. Dosing ECT treatments on the basis of the ictal EEG: A preliminary study.
  238. Krystal, A.D., Zaidman, C., Greenside, H.S., Weiner, R.D., Coffey, C.E. The largest Lyapunov exponent of the EEG during ECT seizures as a measure of therapeutic adequacy. Electroencephalography and Clinical Neurophysiology 103:599-606, 1997.
  239. Krystal, A.D., Coffey, C.E. Neuropsychiatric considerations in the use of Electroconvulsive Therapy. Journal of Neuropsychiatry and Clinical Neurosciences 9:283-292, 1997.
  240. Krystal, A.D. The clinical utility of ictal EEG seizure adequacy models. Psychiatric Annals, 1:30-35, 1998.
  241. Krystal, A.D., Greenside, H.S. Low Dimensional Chaos in Bipolar Disorders? (Letter to the Editor) Arch. Gen. Psychiatry (in press).
  242. Krystal, A.D., Coffey, C.E., Weiner, R.D., Holsinger, T. Changes in seizure threshold over the ECT course affect therapeutic response and are detected by ictal EEG ratings. J. Neuropsychiatry & Clin. Neurosci. in press.
  243. Krystal, A.D., Weiner, R.D. EEG Correlates of the response to ECT: A possible antidepressant role of brain derived neurotrophic factor, Journal of ECT.
  244. Krystal, A.D., Holsinger, T., Weiner, R.D., Coffey, C.E., Predicting unilateral ECT response and the utility of a switch to bilateral ECT with treatment 2 ictal EEG indices.
  245. Krystal, AD; Coffey, CE, Neuropsychiatric considerations in the use of electroconvulsive therapy., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 9 no. 2 (1997), pp. 283-292, ISSN 0895-0172 [9144111], [doi]  [abs]
  246. Zoldi, SM; Krystal, AD; Greenside, HS, Statistical analysis of redundancy and stationarity in multi-channel EEG., Journal of Mathematical Psychology, vol. 40 no. 4 (December, 1996), pp. 354-355, ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS, ISSN 0022-2496 [Gateway.cgi]
  247. Krystal, AD; Greenside, HS; Weiner, RD; Gassert, D, A comparison of EEG signal dynamics in waking, after anesthesia induction and during electroconvulsive therapy seizures., Electroencephalography and Clinical Neurophysiology, vol. 99 no. 2 (August, 1996), pp. 129-140, ISSN 0013-4694 [8761049], [doi]  [abs]
  248. Edinger, JD; Fins, AI; Goeke, JM; McMillan, DK; Gersh, TL; Krystal, AD; McCall, WV, The empirical identification of insomnia subtypes: a cluster analytic approach., Sleep, vol. 19 no. 5 (June, 1996), pp. 398-411, ISSN 0161-8105 [8843531]  [abs]
  249. Krystal, AD; Weiner, RD; Coffey, CE; McCall, WV, Effect of ECT treatment number on the ictal EEG., Psychiatry Research, vol. 62 no. 2 (May, 1996), pp. 179-189, ISSN 0165-1781 [8771615], [doi]  [abs]
  250. Krystal, AD; Weiner, RD; Gassert, D; McCall, WV; Coffey, CE; Sibert, T; Holsinger, T, The relative ability of three ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response., Convulsive Therapy, vol. 12 no. 1 (March, 1996), pp. 13-24, ISSN 0749-8055 [8777648]  [abs]
  251. Coffey, CE; Weiner, RD; Krystal, AD, The anticonvulsant properties of ECT., Convulsive Therapy, vol. 12 no. 1 (March, 1996), pp. 64-64, LIPPINCOTT-RAVEN PUBL, ISSN 0749-8055 [Gateway.cgi]
  252. Krystal, A.D., Weiner, R.D., Coffey, C.E., McCall, W.V. The effect of ECT treatment number on the ictal EEG. Psychiatry Research 62:179-189, 1996.
  253. Krystal, A.D., Zaidman, C., Greenside, H.S., Weiner, R.D., Coffey, C.E. The largest Lyapunov exponent of the EEG during ECT seizures as a measure of therapeutic adequacy.
  254. Krystal, A.D., Weiner, R.D., Gassert, D., McCall, W.V., Coffey, C.E., Sibert, T., Holsinger, T. The relative ability of 3 ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response. Convulsive Therapy 12:13-24, 1996..
  255. Krystal, A.D., Greenside, H.S., Weiner, R.D., Gassert, D. A comparison of EEG signal dynamics in waking, after anesthesia induction and during ECT seizures. Electroencephalography and Clinical Neurophysiology 99:129-140, 1996.
  256. Krystal, A.D., Greenside, H.S. Low Dimensional Chaos in Bipolar Disorders? (Letter to the Editor) Arch. Gen. Psychiatry (in press).
  257. Krystal, A.D., Coffey, C.E., Weiner, R.D., Holsinger, T. Changes in seizure threshold over the ECTcourse affect therapeutic response and are detected by ictal EEG ratings.
  258. Steffens, DC; Krystal, AD; Sibert, TE; Moore, SD; Weiner, RD, Cost effectiveness of maintenance ECT., Convulsive Therapy, vol. 11 no. 4 (December, 1995), pp. 283-284, ISSN 0749-8055 [8919583]
  259. Krystal, AD; Weiner, RD, ECT seizure duration: reliability of manual and computer-automated determinations., Convulsive Therapy, vol. 11 no. 3 (September, 1995), pp. 158-169, ISSN 0749-8055 [8528657]  [abs]
  260. Coffey, CE; Lucke, J; Weiner, RD; Krystal, AD; Aque, M, Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT., Biological Psychiatry, vol. 37 no. 11 (June, 1995), pp. 777-788, ISSN 0006-3223 [7647162], [doi]  [abs]
  261. Coffey, CE; Lucke, J; Weiner, RD; Krystal, AD; Aque, M, Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold., Biological Psychiatry, vol. 37 no. 10 (May, 1995), pp. 713-720, ISSN 0006-3223 [7640326], [doi]  [abs]
  262. Edinger, JD; Erwin, CW; Fins, AI; Marsh, GR; Krystal, AD, Ambulatory cassette polysomnography: findings from a large cohort of drug-free insomnia patients., Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society, vol. 12 no. 3 (May, 1995), pp. 302-309, ISSN 0736-0258 [11221789]  [abs]
  263. Krystal, A.D., Greenside, H.S., Weiner, R.D., Gassert, D. A comparison of EEG signal dynamics in waking, after anesthesia induction and during ECT seizures.
  264. Review of John S. Barlow, The Electroencephalogram: It's Patterns and Origins, MIT Press, Cambridge, 1993, Biomedical Instrumentation & Technology 29:363, 1995.
  265. Krystal, A.D., Weiner, R.D., Coffey, C.E. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J. Neuropsychiatr. and Clin. Neurosciences 7:295-303, 1995.
  266. Krystal, A.D., Weiner, R.D., Gassert, D., McCall, W.V., Coffey, C.E., Sibert, T., Holsinger, T. The relative ability of 3 ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response. Convulsive Therapy (In Press).
  267. Krystal, AD; Weiner, RD; Coffey, CE, The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 7 no. 3 (1995), pp. 295-303, ISSN 0895-0172 [7580187], [doi]  [abs]
  268. Krystal, AD; Weiner, RD, ECT seizure therapeutic adequacy., Convulsive Therapy, vol. 10 no. 2 (June, 1994), pp. 153-164, ISSN 0749-8055 [8069641]  [abs]
  269. Krystal AD, Weiner RD: ECT seizure therapeutic adequacy. Convulsive Therapy 10: 153-164, 1994.
  270. Krystal H, Krystal AD: Psychoanalysis and neuroscience in relationship to dreams and creativity. In (eds., Shaw MP, Runco MA), Creativity and Affect. New Jersey: Ablex Publishing Corp., 1994.
  271. Krystal AD, Weiner RD: Low frequency ictal EEG activity and ECT therapeutic impact. Convulsive Therapy 9: 220-224, 1993.
  272. McCall WV, Edinger JD, Krystal AD, Marsh GR: Ambulatory polysomnogrophic differences in healthy and insomniac older men. Ambulatory monitoring 6: 135-140, 1993.
  273. Krystal AD, Weiner RD, McCall WV, Shelp F, Arias R, Smith P: The effects of ECT stimulus dose and electrode placement on the ictal electroencehpalogram: An intraindividual crossover study. Biological Psychiatry 34: 759-767, 1993.
  274. Weiner RD, Krystal AD: EEG monitoring of ECT seizures. In (ed Coffey CE), The Clinical Science of Electroconvulsive Therapy. Washington DC: American Psychiatric Press, Inc., pp 93-109, 1993.
  275. Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M: Seizure threshold in electroconvulsive therapy. I. Initial seizure threshold. Biological Psychiatry, in press.
  276. Weiner, RD; Krystal, AD, The present use of electroconvulsive therapy., Annual Review of Medicine, vol. 45 (1994), pp. 273-281, ISSN 0066-4219 [8198383], [doi]  [abs]
  277. Krystal, AD; Weiner, RD; McCall, WV; Shelp, FE; Arias, R; Smith, P, The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study., Biological Psychiatry, vol. 34 no. 11 (December, 1993), pp. 759-767, ISSN 0006-3223 [8292679], [doi]  [abs]
  278. Krystal, AD; Weiner, RD, Low-Frequency Ictal EEG Activity and ECT Therapeutic Impact., Convulsive Therapy, vol. 9 no. 3 (1993), pp. 220-224, ISSN 0749-8055 [11941217]
  279. Krystal, AD; Weiner, RD; Coffey, CE; Smith, P; Arias, R; Moffett, E, EEG evidence of more "intense" seizure activity with bilateral ECT., Biological Psychiatry, vol. 31 no. 6 (March, 1992), pp. 617-621, ISSN 0006-3223 [1581442], [doi]
  280. McCall, WV; Erwin, CW; Edinger, JD; Krystal, AD; Marsh, GR, Ambulatory polysomnography: technical aspects and normative values., Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society, vol. 9 no. 1 (January, 1992), pp. 68-77, ISSN 0736-0258 [1552010]  [abs]
  281. Weiner, RD; Krystal, AD; Coffey, CE; Smith, P, The electrophysiology of ECT: relevance to mechanism of action., Clinical Neuropharmacology, vol. 15 Suppl 1 Pt A (1992), pp. 671A-672A, ISSN 0362-5664 [1498995]
  282. Weiner, RD; Coffey, CE; Krystal, AD, The monitoring and management of electrically induced seizures., The Psychiatric Clinics of North America, vol. 14 no. 4 (December, 1991), pp. 845-869, ISSN 0193-953X [1771151], [doi]  [abs]
  283. Krystal, AD; McEvoy, JP, Shared features of neuroleptic malignant syndrome and alcohol abuse complications., The Journal of Clinical Psychiatry, vol. 51 no. 12 (December, 1990), pp. 523, ISSN 0160-6689 [2258367]
  284. Krystal, A; Krishnan, KR; Raitiere, M; Poland, R; Ritchie, JC; Dunnick, NR; Hanada, K; Nemeroff, CB, Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder., The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 2 no. 1 (1990), pp. 34-43, ISSN 0895-0172 [1967010], [doi]  [abs]

Papers Published

  1. Dieffenderfer, J; Krystal, A; Bozkurt, A, Shedding light to sleep studies, Smart Structures and Materials 2005: Active Materials: Behavior and Mechanics, vol. 10352 (January, 2017), SPIE, ISBN 9781510611610 [doi]  [abs]
  2. Manber, R; Buysse, DJ; Edinger, J; Krystal, A; Luther, JF; Wisniewski, SR; Trockel, M; Kraemer, HC; Thase, ME, Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial., The Journal of Clinical Psychiatry, vol. 77 no. 10 (October, 2016), pp. e1316-e1323 [doi]  [abs]
  3. Leuchter, AF; Cook, IA; Feifel, D; Goethe, JW; Husain, M; Carpenter, LL; Thase, ME; Krystal, AD; Philip, NS; Hunter, AM; Burke, WJ; Howland, RH; Sheline, YI; Aaronson, ST; Iosifescu, DV; O'Reardon, J; Gilmer, WS; Jain, R; Bugoyne, K; Massaro, J; Lisanby, SH; George, MS, Can We Use Brain Oscillations to Guide Treatment of MDD?, Biological Psychiatry, vol. 77 no. 9 (May, 2015), pp. 37S-38S, ELSEVIER SCIENCE INC, ISSN 0006-3223 [Gateway.cgi]
  4. Tek, C; Palmese, LB; Krystal, AD; DeGeorge, PC; Reutenauer, EL; Guloksuz, S, The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial, Biological Psychiatry, vol. 75 no. 9 (May, 2014), pp. 341S-342S, ELSEVIER SCIENCE INC, ISSN 0006-3223 [Gateway.cgi]
  5. Valero-Sarmiento, JM; Bhattacharya, S; Krystal, A; Bozkurt, A, Towards injectable biophotonic sensors for physiological monitoring of animals, Proceedings of Ieee Sensors, vol. 2014-December no. December (January, 2014), pp. 503-506, IEEE, ISSN 1930-0395 [doi]  [abs]
  6. Deng, ZD; Peterchev, AV; Krystal, AD; Luber, B; McClintock, SM; Husain, MM; Lisanby, SH, Topography of seizures induced by electroconvulsive therapy and magnetic seizure therapy, International Ieee/Embs Conference on Neural Engineering, Ner (December, 2013), pp. 577-580, IEEE, ISSN 1948-3546, ISBN 9781467319690 [doi]  [abs]
  7. Krystal, AD; Preud'homme, XA; Goforth, HW, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ESZOPICLONE FOR THE TREATMENT OF INSOMNIA IN PATIENTS WITH CHRONIC LOW BACK PAIN, Sleep, vol. 35 (January, 2012), pp. A216-A216, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  8. Buysse, DJ; Krystal, AD; Johnston, K; Dodds, N; Yu, L; Giang, R; Pilkonis, P, SLEEP AND HEALTH-RELATED FUNCTION IN A CLINICAL SAMPLE AS MEASURED BY PROMIS (PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM), Sleep, vol. 35 (January, 2012), pp. A133-A133, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  9. Krystal, AD; Roth, T; Pong, A; Stet, L; Ivgy-May, N, EFFICACY AND SAFETY OF ESMIRTAZAPINE IN ELDERLY PATIENTS WITH PRIMARY INSOMNIA IN A 2-WEEK SLEEP LABORATORY TRIAL, Sleep, vol. 35 (January, 2012), pp. A222-A222, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  10. Roth, T; Hull, SG; Singh, NN; Steinberg, F; Krystal, AD, GENDER EFFECTS OF 1.75 MG AND 3.5 MG ZOLPIDEM TARTRATE SUBLINGUAL TABLETS FORMULATED WITH A CARBONATE-BICARBONATE BUFFER ON SLEEP ONSET FOLLOWING MIDDLE-OF-THE-NIGHT AWAKENING AND ON NEXT-DAY RESIDUAL EFFECTS, Sleep, vol. 35 (January, 2012), pp. A225-A226, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  11. Edinger, JD; Means, MK; Krystal, AD, ARE INSOMNIA SUFFERERS' DAYTIME DEFICITS PRODUCTS OF SUBJECTIVE DISTORTIONS?, Sleep, vol. 35 (January, 2012), pp. A230-A230, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  12. Edinger, JD; Means, MK; Krystal, AD, DOES HYPERAROUSAL INCREASE DAYTIME ERROR PRONENESS AMONG INSOMNIA SUFFERERS?, Sleep, vol. 35 (January, 2012), pp. A214-A214, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  13. Preud'homme, XA; Lohri, J; Amundsen, CL; Peterson, A; Webster, GD; Krystal, AD, NOCTURIA IN SUBJECTS WITH OVERACTIVE BLADDER SYNDROME (OAB): WHAT WAKES THEM UP?, Sleep, vol. 35 (January, 2012), pp. A309-A309, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  14. Rose, JE; McClernon, FJ; Froeliger, B; Behm, FM; Preud'homme, X; Krystal, AD, Repetitive Transcranial Magnetic Stimulation (rTMS) of the Superior Frontal Gyrus Modulates Craving for Cigarettes, Biological Psychiatry, vol. 69 no. 9 (May, 2011), pp. 277S-278S, ELSEVIER SCIENCE INC, ISSN 0006-3223 [Gateway.cgi]
  15. Palmese, LB; DeGeorge, PC; Srihari, VH; Wexler, BE; Krystal, AD; Tek, C, SLEEP PATTERNS OF INDIVIDUALS WITH SCHIZOPHRENIA, Schizophrenia Bulletin, vol. 37 (March, 2011), pp. 277-277, OXFORD UNIV PRESS, ISSN 0586-7614 [Gateway.cgi]
  16. Lankford, A; Krystal, AD; Dorsey, B; Rogowski, R; Ludington, E; Durrence, H; Davis, CS; Roth, T, PATIENT-REPORTED SYMPTOM IMPROVEMENT IN SLEEP MAINTENANCE ENDPOINTS IN ADULT AND ELDERLY PATIENTS WITH INSOMNIA TREATED WITH DOXEPIN 3 AND 6 MG, Sleep, vol. 34 (January, 2011), pp. A175-A175, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  17. Preud'homme, XA; Amundsen, CL; Webster, GD; Jiang, W; Kuchibhatla, M; Krystal, AD, AUTONOMIC NERVOUS SYSTEM ACTIVITY PRECEDING NOCTURIA IN OLDER ADULTS, Sleep, vol. 34 (January, 2011), pp. A241-A241, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  18. Krystal, AD; Lankford, A; Dorsey, B; Rogowski, R; Ludington, E; Durrence, H; Roth, T, IMPROVEMENT IN SLEEP MAINTENANCE AND EARLY MORNING AWAKENINGS IN ADULT AND ELDERLY PATIENTS WITH INSOMNIA TREATED WITH DOXEPIN 3 AND 6 MG, Sleep, vol. 34 (January, 2011), pp. A182-A182, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  19. Krystal, AD; Grinnell, T; Spalding, W; Zummo, J; Schweizer, E; Marshall, RD, A POSTHOC ANALYSIS OF ESZOPICLONE EFFECTS ON CARDIOMETABOLIC INDICES OF HYPERAROUSAL IN THE TREATMENT OF PRIMARY INSOMNIA, Sleep, vol. 34 (January, 2011), pp. A175-A175, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  20. Manber, R; Suh, S; Buysse, DJ; Edinger, JD; Cardell, C; Cardell, J; Krystal, AD, OBSTRUCTIVE SLEEP APNEA (OSA) IN MAJOR DEPRESSIVE DISORDER, Sleep, vol. 34 (January, 2011), pp. A256-A257, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  21. Edinger, JD; Wyatt, JK; Olsen, MK; Stechuchak, KM; Carney, CE; Chiang, A; Krystal, AD; Means, MK; Radtke, RA, How valid are the DSM-IV-TR and ICSD-2 insomnia nosologies? Preliminary results from a multi-trait/multi-method diagnostic trial, Sleep, vol. 31 (January, 2008), pp. A249-A249, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  22. Richey, SM; Weiner, RD; Edinger, JD; Preud'homme, X; Carney, CE; Krystal, AD, Change in sleep correlates with change in post-dexamethasone cortisol in patients with refractory depression treated with ECT, Sleep, vol. 31 (January, 2008), pp. A244-A244, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  23. Krystal, AD; Scharf, MB; Mordy, C; Singh, N; Maytom, M, Pharmacokinetics of a low dose, sublingual formulation of zolpidem tartrate in elderly subjects, Sleep, vol. 31 (January, 2008), pp. A234-A235, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  24. Krystal, AD; Kahn, R; Maguire, Y; Singh, N; Maytom, M, A pharmacokinetic study of the co-administration of a high fat meal with a low dose, sublingual formulation of zolpidem tartrate, Sleep, vol. 31 (January, 2008), pp. A34-A34, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  25. Ohayon, MM; Guilleminault, C; Black, J; Wells, C; Krystal, AD, Evolution of narcolepsy symptoms in families, Sleep, vol. 31 (January, 2008), pp. A213-A213, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  26. Rosenberg, R; Krystal, AD; Novak, J; Maguire, Y; Mordy, C; Singh, N; Maytom, M, Frequency and timing of middle-of-the-night (MOTN) awakenings as described using an interactive voice response system, Sleep, vol. 31 (January, 2008), pp. A235-A235, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  27. Roth, T; Krystal, AD; Maguire, Y; Singh, N; Maytom, M, Pharmacokinetics of the sublingual zolpidem tartrate 3.5mg lozenge compared to the oral zolpidem tartrate 10 mg tablet, Sleep, vol. 31 (January, 2008), pp. A235-A235, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  28. Carney, CE; Edinger, JD; Olsen, MK; Stechuchak, KM; Krystal, AD; Wyatt, JK, Inter-rater reliability for insomnia diagnoses derived from the duke structured interview for sleep disorders, Sleep, vol. 31 (January, 2008), pp. A250-A250, AMER ACAD SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  29. Krystal, AD; Dinges, DF, Modafinil improves performance requiring sustained attention in patients with narcolepsy, Annals of Neurology, vol. 62 (January, 2007), pp. S80-S80, WILEY-LISS, ISSN 0364-5134 [Gateway.cgi]
  30. Carney, CE; Edinger, JD; Krystal, AD; Stepanski, EJ; Kirby, A, Are insomnia patients pathologically worried or simply worried about sleep?, Sleep, vol. 29 (January, 2006), pp. A234-A234, AMER ACADEMY SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  31. Carney, CE; Edinger, JD; Krystal, AD; Stepanski, EJ; Kirby, A, The contribution of anxiety to sleep quality reporting in insomnia subtypes, Sleep, vol. 29 (January, 2006), pp. A233-A233, AMER ACADEMY SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  32. Rubens, R; Krystal, AD; Wessel, TC; Roth, T; Caron, J; Amato, DA, Efficacy of eszopiclone in the treatment of sleep maintenance insomnia, Neurology, vol. 64 no. 6 (March, 2005), pp. A46-A46, LIPPINCOTT WILLIAMS & WILKINS, ISSN 0028-3878 [Gateway.cgi]
  33. Wessel, TC; Roth, T; Krystal, AD; Caron, J; Amato, DA, Twelve months of nightly eszopiclone treatment in patients with chronic insomnia: Assessment of long-term efficacy and safety, Neurology, vol. 64 no. 6 (March, 2005), pp. A46-A46, LIPPINCOTT WILLIAMS & WILKINS, ISSN 0028-3878 [Gateway.cgi]
  34. Litsch, S; Michaels, C; Carney, C; Edinger, JJ; Wohlgemuth, WK; Krystal, AD, A pilot study of the sleep EEG power spectral effects of relaxation training in primary insomniacs, Sleep, vol. 28 (January, 2005), pp. A255-A255, AMER ACADEMY SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  35. Wohlgemuth, WK; Edinger, JD; Krystal, AD; Rice, JR, Behavioral insomnia therapy for patients with fibromyalgia: An update, Sleep, vol. 26 (May, 2003), pp. A368-A368, AMER ACADEMY SLEEP MEDICINE, ISSN 0161-8105 [Gateway.cgi]
  36. Becker, PM; Jamieson, AO; Jewel, CE; Bogan, RK; James, DS; Sutton, JT; Corser, B; Mayleben, DW; Bernard, SH; Dinner, DS; Emsellem, H; Knight, E; Erwin, CW; Krystal, AD; Radtke, RA; Farrow, S; Odynski, T; Pinto, J; Steljes, D; Feldman, NT; O'Brien, M; Fredrickson, PA; Kaplan, J; Lin, SC; Burger, C; Fry, JM; Guilleminault, C; Black, J; Green, PM; Schmitigal, L; Gross, PT; Dignan, S; Harsh, J; Hartwig, G; Haynes, JB; Hageman, M; Porter-Shirley, K; Hertz, G; Hirshkowitz, M; Moore, CA; Iyer, V et al., Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group., Neurology, vol. 54 no. 5 (March, 2000), pp. 1166-1175, Ovid Technologies (Wolters Kluwer Health), ISSN 0028-3878 [Gateway.cgi], [doi]  [abs]
  37. Fry,, Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy, Annals of Neurology, vol. 43 no. 1 (January, 1998), pp. 88-97, WILEY, ISSN 0364-5134 [Gateway.cgi], [doi]
  38. KRYSTAL, AD; WEINER, RD, THE LARGEST LYAPUNOV EXPONENT OF THE EEG IN ECT SEIZURES, edited by Duke, DW; Pritchard, WS, Proceedings of the Conference on Measuring Chaos in the Human Brain (January, 1991), pp. 113-&, WORLD SCIENTIFIC PUBL CO PTE LTD, ISBN 981-02-0701-8 [Gateway.cgi]